Eli Lilly and Company (LLY)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	2,920,000	933,700	234,000	-629,900	-1,337,200	-1,535,600	-282,100	-575,400	564,300	647,900	1,187,200	881,300	-483,600	139,600	-688,500	-476,400	-138,600	1,226,100	1,652,600	1,613,500
Revenue (ttm)	US$ in thousands	45,042,700	40,863,300	38,922,800	35,932,100	34,124,100	32,072,500	29,515,500	27,691,400	28,541,400	29,239,500	29,070,700	29,322,800	28,318,400	27,758,500	26,726,300	25,485,600	24,539,800	23,213,800	22,949,800	23,087,100
Operating profit margin		6.48%	2.28%	0.60%	-1.75%	-3.92%	-4.79%	-0.96%	-2.08%	1.98%	2.22%	4.08%	3.01%	-1.71%	0.50%	-2.58%	-1.87%	-0.56%	5.28%	7.20%	6.99%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $2,920,000K ÷ $45,042,700K
= 6.48%

Eli Lilly and Company's operating profit margin has fluctuated over the periods provided in the data. The company experienced a positive operating profit margin in the range of around 5% to 7% in the first half of 2020, with a peak of 7.20% in June 2020. However, the trend reversed in the latter half of 2020 and into 2021, with operating profit margins turning negative, reaching as low as -2.58% in June 2021.

From March 2022 onwards, there was a gradual improvement in the operating profit margin, with the company returning to positive territory, ranging from 1.98% to 4.08% through June 2024. Notably, there was a significant improvement in the operating profit margin in December 2024, reaching 6.48%.

Overall, Eli Lilly and Company's operating profit margin performance demonstrates periods of volatility and fluctuations, with efforts to recover and improve profitability observed in recent quarters. Monitoring future trends will be crucial to assess the company's ongoing financial health and operating efficiency.